紀要論文 Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma : study protocol for a non-randomized non-controlled trial

Mori, Tetsuya  ,  Asada, Ryuta  ,  Saito, Akiko M.  ,  Kada, Akiko  ,  Sekimizu, Masahiro  ,  Fukano, Reiji  ,  Nagai, Hirokazu

79 ( 3 )  , pp.407 - 413 , 2017-08 , Nagoya University Graduate School of Medicine, School of Medicine
ISSN:0027-7622
本文を読む

http://ir.nul.nagoya-u.ac.jp/jspui/bitstream/2237/26918/1/13_Nagai.pdf

このアイテムのアクセス数:  回

その他の情報